When accessing the CDB site through an internal Novo Nordisk IP address, you will see "Your Location" as NN Internal instead of a country. This only applies to internal NN IP addresses. Thank you for your patience while the development team is upgrading this feature.

Your Location: USA

Help Join the Cause Submit Data

Help

About the Changing Diabetes® Barometer

  1. What is the Changing Diabetes® Barometer (CDB)?
    The Changing Diabetes® Barometer is a Novo Nordisk initiative that aims at responding to the global diabetes pandemic by collecting and sharing data for diabetes care worldwide. In addition to collecting existing data, CDB encourages the measurement of outcomes and facilitates sharing of knowledge so that doctors, people with diabetes, and other stakeholders can integrate the data and learn what works in which conditions. It is aimed at driving improvement of diabetes care, thereby saving human lives and reducing the economic burden on healthcare systems and society.


  2. How can CDB help or make a difference?
    The Changing Diabetes® Barometer initiative adds 'outcomes' to the diabetes care debate (measuring key indicators, such as HbA1c, blood pressure, lipids, BMI, complications). It goes beyond drug treatments by looking at factors such as access to care and implementation of national diabetes programmes. For doctors it is a valuable tool to find ways to improve the care they deliver. It enables patient advocacy groups to engage more effectively with healthcare funders and providers, while legislators can assess what progress they are making in combating diabetes.


  3. Who is involved in CDB?
    The initiative brings together an assortment of relevant stakeholders: people with diabetes, healthcare professionals, academics, patient and professional organisations, governments, industry, and media. Only a collaborative approach can achieve the outset goals of CDB. Discussions with the International Diabetes Federation are in progress, and agreements have been made to openly share data and cooperate on data collections, events, etc. The collaborative approach of the CDB initiative was demonstrated at the recent Barometer Seminar held in Oxford. The event brought together over 120 people from 20 countries exchanging experiences and ideas relating to the measuring and sharing of data.


  4. What are the objectives of CDB?
    The main objective of CDB is to place people with diabetes and the importance of quality of care at the center of the CDB initiative. The best way to do this is through measuring and sharing data to increase awareness of the need for improvements in diabetes prevention, treatment, and care. Data can help to measure change and can often be the essential element that can guide the actions to change diabetes. The Changing Diabetes® Barometer initiative is a 'work in progress' that requires continuous input and support to achieve its goal of positively affecting diabetes care by reducing human and economic costs.


  5. Who funds CDB?
    Novo Nordisk is currently funding the CDB initiative.


  6. Who owns CDB?
    Novo Nordisk developed the CDB initiative as an open-source framework – we do not own the data, we merely indicate where published information is available and help to understand it. The initiative, as intended, has now developed into a multi-stakeholder project, with Novo Nordisk as the central catalyst and facilitator.


  7. Is CDB in competition with the IDF Diabetes Atlas? If not, why are some statistics between the two different?
    No. The CDB site and the Atlas are complementary tools for action on and improvement of diabetes care, as acknowledged by both the IDF and Novo Nordisk.

    Although this website benefits greatly from data collected by and published in the Diabetes Atlas by the International Diabetes Federation (IDF), sometimes the data published on this site will differ from that found on the Diabetes Atlas. This will normally be the result of one of the following situations:

    • CDB or Diabetes Atlas may have updated information before the other
    • Information on Diabetes Atlas has been available since the publication of the Atlas
    • CDB may have different information or recommendations from local diabetes sources than the Diabetes Atlas


  8. What editorial control, if any, is exercised over data presented?
    Apart from expert review to ensure quality of data submitted, this website exercises no further editorial control over the data which appears.


The Changing Diabetes® Barometer Website

  1. What is in the CDB website?

    The website is the tangible result of the data gathering process of the CDB initiative – a 'work in progress' that further encourages the collection and dissemination of outcomes data for diabetes care. The site is divided into 5 primary areas:

    1. Diabetes Pandemic This section sets the stage by describing the current global situation of diabetes. As data shows, if left untreated, the situation will grow to historic proportions, resulting in not only tremendous pain and suffering to the hundreds of millions with the disease, but also represent tremendous costs to society. You can learn more about diabetes and the people at risk for developing diabetes, as well as about diabetes types, diabetes indicators, and diabetes complications. The situation is not hopeless. Learn how reversing diabetes trends is not only possible, but essential.


    2. Diabetes Data This could be considered the heart of the CDB website, as this is where you will be able to benchmark data in the following four areas:



    3. About the Barometer. This section describes the importance of data, how the data is collected, lists other Changing Diabetes® initiatives, and provides insight into our future objectives. This is also where you can find the press kit.


    4. Be Inspired. Benchmark the national plan of your country against others and learn about Barometer best practices. You will find a full library of videos addressing different diabetes topics, as well as listing of diabetes events around the world. Be sure to read the diabetes facts.


    5. Make a Difference. We hope that after seeing the importance of CDB you will lend your support and join the cause. Once you register, you can then submit data or tell your story.


  2. How does it work?
    When you arrive on the site, it will recognize where you are by the IP address of your computer and present you with content and data that is specific to your location. Location-specific content includes: National Plans and Diabetes Data where the default for the primary country you benchmark data against will be your location.

    There may be cases where we do not recognize your IP address. When this happens you will be able to select your country from the "Change Country" dropdown available at the top of every page. If your country is not available, we may not have data for that country. Feel free to send us an email and submit data for your country here.


  3. How do I change my location?
    You can change your location on any page of the site by using the dropdown menu located in the top right section of the page. Once you change your location, content for that country will continue to be served during your visit unless you change it once again. When you leave the site or refresh the home page, the IP address will once again determine your location, and where relevant, serve location-specific material.

    In the Diabetes Data section, you can change the primary country which you are benchmarking data against using the dropdown menu on the page. (See next.)


  4. How do I use the dropdown menu in the Diabetes Data section?
    1. To change primary country:

      By default, the Diabetes Data section will display data specific to the country identified by your IP Address.

      1. To change that country (which will appear in red in the right hand box), select it and click REMOVE.
      2. Then add a new primary country by selecting a region from the drop down box.
      3. Then select a country from the corresponding list and click ADD.
    2. Add countries to compare:

      Once a primary country has been selected, all additional countries added will be compared.

      1. First, select a region from the drop down box on the left hand side.
      2. Click the name of the country in the left box and hit ADD. You will then see that country added to the box on the right.
      3. To remove a country, click on it in the right box, hit REMOVE, and it will return to the list of countries on the left.

      Once you add countries, the first chart showing measurements specific to your primary country will drop to the bottom of page, and the list of charts reflecting benchmarking information appear in order beginning from the top of the page.



  5. How can I download or share data found on the site?
    1. Share the website:

      Any page of the website can be shared by using the "Bookmark & Share" tool located on the upper right section of every page:

      Additionally this button is available in the Diabetes Data section to share specific graphs.

    2. Downloading Data:

      You can download data for each graph by selecting the "Download" option and choosing the desired format. Available formats are:

      • .xls (data in an excel workbook)
      • .jpg (the graph as an image)


  6. What does "Download A Full Country Report" mean?
    When you select "Download A Full Country Report," you download a PDF containing all of the diabetes data available for the primary country selected.


  7. How often is the website updated? How will I know when the site is updated?
    The website will be updated on a regular basis when new data becomes available. Currently there is no newsletter, but by joining the cause and indicating that you give Novo Nordisk permission to email you, when there is news about the website or the CDB initiative, you will be contacted.


  8. Can content found on this site be reused (like data and videos)?
    The copyright on all data remains with the original owners, and no data may be used for commercial purposes by website users. The data has been made available by the owners as part of a collaborative global effort to drive improvement of diabetes care, thereby saving human lives and reducing the economic burden on healthcare systems and society.

    Therefore, as long as the use of content is not for commercial gain or purpose, and credit is given to Novo Nordisk and ChangingDiabetesBarometer.com, you are free to reuse the content found on this site.

    Feel free to contact us if you have any questions.



About the Data

  1. How is the data available on this site collected?
    Data is collected in various ways and through various circumstances. Most of the data shared in CDB website is from governmental studies, registries, etc. All data on the site has been reviewed and must meet the standards set by members of the Global Changing Diabetes® Barometer Advisory Board.

    The overall philosophy is that 'any data is better than no data' – a consequence of the combination of poor availability of data worldwide on the one hand, and the CDB mindset of having a base, and improving from that base, on the other. However, in order to ensure the website as a credible source of data, some data sets have been discarded, and moving forward we have embraced a more critical attitude to determining the data to include based upon its origin and source.


  2. How can this data be used?
    Visitors can measure results for their location or benchmark the data against other countries. Data can be printed, shared, and downloaded as a spreadsheet or PDF document.

    We encourage visitors to our site to make comparisons with the data that will inspire and motivate you to act and share your findings. We realize that gaps in the data available on this site exist. Most importantly, because information around the world is often collected in different ways and use different methods and standards, site users should beware of drawing conclusions, because comparisons are only valid if the circumstances and populations are similar.


  3. Why is data not available for some countries or for certain areas of information?
    The CDB initiative is a "work in progress." For various reasons, either because data has not been submitted to the initiative or does not yet exist, some data might not be accessible.


  4. How will these gaps be addressed?
    The aim of the CDB initiative is to gather and share data on diabetes. The website invites interaction and participation, as well as submission of data, and only through a collaborative approach can diabetes outcomes be improved.


  5. Who owns the data?
    The individuals and/or organisations who collect and publish the data own it. In cases where Novo Nordisk has been instrumental in providing the data, it will be shared openly without Novo Nordisk taking formal ownership of the data


  6. How can new data be submitted for evaluation and inclusion in this site?
    At the top of every page in the website are links to Join the Cause and Submit Data. You can only submit data once you have registered ( Join the Cause ). The information you submit will be reviewed by Novo Nordisk. If the material meets the criteria, someone at Novo Nordisk will contact you. If you have any questions, please email barometer@novonordisk.com.


About Novo Nordisk

  1. What is Novo Nordisk's role in all this?
    Novo Nordisk is collecting and openly sharing all the available information on diabetes care by working closely with international partners. Novo Nordisk provides the platform for this process of measuring, sharing, and improving diabetes outcomes.


  2. Why is Novo Nordisk behind this?
    As part of our commitment to changing diabetes and improving the lives of people with diabetes, Novo Nordisk launched the Changing Diabetes® Barometer initiative in November 2007, and at that time published a report showing the data availability in a number of selected countries. As a leader in diabetes care, we have a responsibility to ini-tiate processes to improve the lives of people with diabetes, and therefore we now follow up on the 2007 report with a more elaborate and truly global initiative.


  3. Who else is Novo Nordisk working with?
    Novo Nordisk is working with a wide range of partners including people with diabetes, healthcare professionals, academics, patient and professional organisations, non-government organisations (NGOs), governments, industry, and media. Only a truly collaborative approach will bring much needed positive change in the fight against diabetes.

Novo Nordisk is a global healthcare company with 87 years of innovation and leadership in diabetes care. The company also has leading positions within haemophilia care, growth hormone therapy, and hormone replacement therapy. Headquartered in Denmark, Novo Nordisk employs approximately 29,650 employees in 76 countries, and markets its products in 179 countries. Novo Nordisk's B shares are listed on NASDAQ OMX Copenhagen (Novo-B). Its ADRs are listed on the New York Stock Exchange (NVO). For more information, visit novonordisk.com.

Return To Top